WHO ICTRP trial
Comparison between the efficacy of intravenous immunoglobulin and convalescent…
IRCT20200413047056N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20200413047056N1 |
|---|---|
| Public title | Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19 |
| Scientific title | Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in improving the condition of patients with COVID-19: A randomized clinical trial |
| Primary sponsor | Birjand University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | COVID-19 disease. |
| Interventions | Intervention 1: Intervention group: In addition to the common national protocol, this group will receive convalescent plasma of recovered individuals twice and 200 cc each time. Intervention 2: Intervention group: In addition to the common… |
| Registration date | Apr 17, 2020 |
| Target size | 15 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: